Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05354_nanopub.RAJqVwV3EkBKHy_43M4WImPyFbwWKHdLR2TIUq0Uj3TfQ#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05354 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05354 label "intranasal morphine [drugbank:DB05354]" assertion.
- drugbank:DB05354 seeAlso DB05354 assertion.
- drugbank:DB05354 description "Rylomine (intranasal morphine), is currently in Phase 3 development in the United States, for moderate-to-severe pain in supervised healthcare settings. It employs the patented and proprietary, Chysis(R) drug-delivery platform to adhere and regularize the kinet" assertion.
- drugbank:DB05354 identifier "drugbank:DB05354" assertion.
- drugbank:DB05354 title "intranasal morphine" assertion.
- drugbank:DB05354 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05354 drugbank_vocabulary:drugbank-id "DB05354" assertion.
- drugbank:DB05354 bio2rdf_vocabulary:x-identifiers.org DB05354 assertion.
- drugbank:DB05354 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05354" assertion.
- drugbank:DB05354 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05354 bio2rdf_vocabulary:identifier "DB05354" assertion.